Voyager Awarded Cancer Research Mission Management Contract

Voyager Technologies (NYSE: VOYG) signed a contract with the Center for the Advancement of Science in Space to manage Symphony Biosciences’ biopolymer cancer implant experiment aboard the International Space Station (ISS). The contract underscores the continued demand for access to low-Earth orbit for biopharmaceutical research.